Viking Therapeutics
Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
VKTX Key Statistics
Stock Snapshot
Viking Therapeutics(VKTX) stock is priced at $39.09, giving the company a market capitalization of 4.53B. It carries a P/E multiple of -9.41.
As of 2026-07-01, Viking Therapeutics(VKTX) stock has fluctuated between $38.71 and $41.40. The current price stands at $39.09, placing the stock +1.0% above today's low and -5.6% off the high.
The Viking Therapeutics(VKTX)'s current trading volume is 3.11M, compared to an average daily volume of 3.59M.
In the last year, Viking Therapeutics(VKTX) shares hit a 52-week high of $43.15 and a 52-week low of $22.96.
In the last year, Viking Therapeutics(VKTX) shares hit a 52-week high of $43.15 and a 52-week low of $22.96.
VKTX News
...
Viking Therapeutics (VKTX) has kicked off a Phase 1 trial of VK3019, a dual amylin and calcitonin receptor agonist for obesity, placing a new clinical asset in...
Analyst ratings
89%
of 19 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.